Please login to the form below

acute coronary syndrome

This page shows the latest acute coronary syndrome news and features for those working in and with pharma, biotech and healthcare.

Novartis and Bayer among backers for European big data project

Its overarching aim is to improve patient outcomes and reduce the burden on society of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS).

Latest news

Another failed trial knocks back AZ's plan to grow Brilinta

Putting a brave face on the verdict, AZ's chief medical officer Sean Bohen said that the "proven benefits of Brilinta in acute coronary syndrome and post-myocardial infarction patients are
AZ's Brilinta disappoints in stroke trial

its approval in its current indication in acute coronary syndrome (ACS).
AstraZeneca wins EU approvals for Zurampic and Brilique

A 90mg dose of Brilique is already available in the EU for adults with acute coronary syndrome (ACS), but the approval of a 60mg dose means that patients with a history
Sanofi will resubmit Lyxumia for FDA approval in Q3

Although the 'Evaluation of Lixisenatide in Acute Coronary Syndrome' (ELIXA) trial failed to meet its original primary objective of demonstrating a reduction in cardiovascular morbidity and mortality, the results are still ... The type 2 diabetes study
Sanofi and Amgen poised for cholesterol drug sales

Data are due in 2017, according to Amgen. Meanwhile, Sanofi and Regeneron are carrying out the ODYSSEY OUTCOMES trial in patients with acute coronary syndrome (ACS) receiving "evidence-based medical therapy ... The primary outcome measure is a composite

More from news
Approximately 7 fully matching, plus 46 partially matching documents found.

Latest Intelligence

Why health psychology is the answer to tackling adherence

In one recent programme that we developed on behalf of AstraZeneca, we assessed the reasons for low adherence in patients with acute coronary syndrome (ACS) who had been prescribed Oral Antiplatelet

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

AZ names Brilique lead in Spain

In this role Gribble will be responsible for the company's marketing of Brilique (ticagrelor) for acute coronary syndrome, including management, development and market access activities, and he will also be ... to save the lives of thousands of people

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Dissecting adherence to personalise patient support

Molloy, G, et al. (2014). Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study.
Understanding the "Big Picture"

A good example would be in acute coronary syndrome (ACS) where there is data to suggest that approximately 350, 000 males in the USA currently suffer from this syndrome.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Manager - MedComms: DOE

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Senior Editorial Assistant – Greater Manchester: DOE

Principal Health Economist - North-West: Negotiable

Account Manager / Account Director: Competative

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Systematic Reviewer - Oxford: Negotiable

Account Manager / Senior Account Manager: 35, 000-40, 000

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

Business Development Director – Health Education: excellent commission

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Client Services Director – Medical Education Agency – North West...: Salary TBC

Associate Director: £75, 000-90, 000

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Account Director – Healthcare Marketing – Berks: Salary TBC

Medical (Scientific) Director: £120, 000 benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Experienced Medical Writers: Competitive Salary and Benefits

Account Manager: Negotiable

Business Director: Competitive Salary Offered

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Subscribe to our email news alerts

PMHub

Add my company

3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today: Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham: Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...